NCT02894892View on ClinicalTrials.gov

Intragastric pH and Bismuth Effect for H. Pylori Eradication

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 15, 2016

Primary Completion Date

October 18, 2017

Study Completion Date

February 20, 2019

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

(A)Bismuth

DRUG

(B)Bismuth

DRUG

(C)Bismuth

DRUG

(D)Esomeprazole and Bismuth

DRUG

(E)Esomeprazole and Bismuth

DRUG

(F)Esomeprazole and Bismuth

OTHER

(G)Control

Trial Locations (1)

10002

National Taiwan University Hospital, Taipei

All Listed Sponsors
collaborator

Ministry of Science and Technology, Taiwan

OTHER_GOV

lead

National Taiwan University Hospital

OTHER

NCT02894892 - Intragastric pH and Bismuth Effect for H. Pylori Eradication | Biotech Hunter | Biotech Hunter